Karyopharm Therapeutics Inc. - Common Stock (KPTI)

8.5500
+0.7000 (8.92%)
NASDAQ · Last Trade: Mar 17th, 2:51 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026